Nevertheless melanoma cultures (KMKD) obtained from a patient before and after treatment with the BRAF inhibitor, vemurafenib showed a decrease in levels of EZH2 protein in the treated cells and a decrease in the GSK126 IC50 values. This evidence concerns the gene EZH2 and melanoma.